Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Effect of bowel cleansing for colonoscopy on fecal calprotectin levels in pediatric patients.

Kolho KL, Alfthan H, Hämäläinen E.

J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):751-3. doi: 10.1097/MPG.0b013e31825f4c77.

PMID:
22614113
2.

Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.

Diamanti A, Colistro F, Basso MS, Papadatou B, Francalanci P, Bracci F, Muraca M, Knafelz D, De Angelis P, Castro M.

Inflamm Bowel Dis. 2008 Sep;14(9):1229-35. doi: 10.1002/ibd.20472.

PMID:
18398894
3.

Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.

Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.

J Gastrointestin Liver Dis. 2014 Sep;23(3):273-8. doi: 10.15403/jgld.2014.1121.233.thv.

4.

Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.

Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.

J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):450-5.

PMID:
15795593
5.

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.

Sidler MA, Leach ST, Day AS.

Inflamm Bowel Dis. 2008 Mar;14(3):359-66.

PMID:
18050298
6.

Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.

Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE.

J Pediatr Gastroenterol Nutr. 2001 Jul;33(1):14-22.

PMID:
11479402
7.

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.

Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S.

Inflamm Bowel Dis. 2008 May;14(5):669-73. doi: 10.1002/ibd.20376.

PMID:
18240279
8.

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.

Kolho KL, Raivio T, Lindahl H, Savilahti E.

Scand J Gastroenterol. 2006 Jun;41(6):720-5.

PMID:
16716972
9.
10.

Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Yang Z, Clark N, Park KT.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028.

11.

Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.

Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, Pellicano R, Astegiano M, Bresso F.

Scand J Gastroenterol. 2014 Dec;49(12):1419-24. doi: 10.3109/00365521.2014.934913.

PMID:
25369978
12.

Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.

Shaoul R, Sladek M, Turner D, Paeregaard A, Veres G, Wauters GV, Escher J, Dias JA, Lionetti P, Staino A, Kolho KL, de Ridder L, Nuti F, Cucchiara S, Sheva O, Levine A; ESPGHAN Porto IBD Group..

Inflamm Bowel Dis. 2012 Aug;18(8):1493-7. doi: 10.1002/ibd.21875.

PMID:
22275268
13.

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels.

Hämäläinen A, Sipponen T, Kolho KL.

World J Gastroenterol. 2011 Dec 21;17(47):5166-71. doi: 10.3748/wjg.v17.i47.5166.

14.

Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.

Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G.

Dig Dis Sci. 2013 Feb;58(2):309-19. doi: 10.1007/s10620-012-2347-5. Review.

PMID:
22899243
15.

Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea.

Licata A, Randazzo C, Cappello M, Calvaruso V, Butera G, Florena AM, Peralta S, Cammà C, Craxì A.

J Clin Gastroenterol. 2012 Jul;46(6):504-8. doi: 10.1097/MCG.0b013e318248f289.

PMID:
22565607
16.

Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.

Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.

J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):414-20.

PMID:
18030206
17.

[Faecal calprotectin in inflammatory bowel disease].

Sipponen T, Kolho KL.

Duodecim. 2011;127(24):2631-7. Review. Finnish.

PMID:
22320105
18.

New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.

Amati L, Passeri ME, Selicato F, Mastronardi ML, Penna A, Jirillo E, Covelli V.

Immunopharmacol Immunotoxicol. 2006;28(4):665-81.

PMID:
17190742
19.

Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.

Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d'Elia H.

Scand J Gastroenterol. 2012 Apr;47(4):435-44. doi: 10.3109/00365521.2011.648953.

PMID:
22229862
20.

Fecal markers: calprotectin and lactoferrin.

Abraham BP, Kane S.

Gastroenterol Clin North Am. 2012 Jun;41(2):483-95. doi: 10.1016/j.gtc.2012.01.007. Review.

PMID:
22500530
Items per page

Supplemental Content

Support Center